These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27847886)

  • 1. Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment.
    Georgiadou SP; Makaritsis KP; Dalekos GN
    J Transl Int Med; 2015; 3(2):43-50. PubMed ID: 27847886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.
    Ejazi SA; Ali N
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):79-98. PubMed ID: 23428104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Leishmaniasis in the Metropolitan City of Multan, Pakistan, a Neglected Tropical Disease.
    Ayaz MM; Nazir MM; Ullah N; Zaman A; Akbar A; Zeeshan M; Hussain Z; Naz S; Zheng Y; Javed A; Lindsay DS
    J Med Entomol; 2018 Jun; 55(4):1040-1042. PubMed ID: 29415246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral miltefosine treatment in children with visceral leishmaniasis: a brief review.
    Palumbo E
    Braz J Infect Dis; 2008 Feb; 12(1):2-4. PubMed ID: 18553005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging medications for the treatment of leishmaniasis.
    Chakravarty J; Sundar S
    Expert Opin Pharmacother; 2019 Jul; 20(10):1251-1265. PubMed ID: 31063412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmaniasis: recognition and management with a focus on the immunocompromised patient.
    Choi CM; Lerner EA
    Am J Clin Dermatol; 2002; 3(2):91-105. PubMed ID: 11893221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
    Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
    BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phlebotomine sand flies (Diptera: Psychodidae) of the Palestinian West Bank: potential vectors of leishmaniasis.
    Sawalha SS; Shtayeh MS; Khanfar HM; Warburg A; Abdeen ZA
    J Med Entomol; 2003 May; 40(3):321-8. PubMed ID: 12943111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological aspects of vector, parasite, and domestic reservoir in areas of recent transmission and no reported human cases of visceral leishmaniasis in Brazil.
    Lara-Silva Fde O; Michalsky ÉM; Fortes-Dias CL; Fiuza Vde O; Pessanha JE; Regina-Silva S; de Avelar DM; Silva MA; Lima AC; da Costa AJ; Machado-Coelho GL; Dias ES
    Acta Trop; 2015 Aug; 148():128-36. PubMed ID: 25882769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric lymphatic leishmaniasis: a case report.
    Kindie EA; Yefter ET; Alemu BA; Gurji TB; Tadesse AK
    J Med Case Rep; 2023 Apr; 17(1):123. PubMed ID: 37020261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis (kala-azar): challenges ahead.
    Singh RK; Pandey HP; Sundar S
    Indian J Med Res; 2006 Mar; 123(3):331-44. PubMed ID: 16778314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent updates and perspectives on leishmaniasis.
    Savoia D
    J Infect Dev Ctries; 2015 Jul; 9(6):588-96. PubMed ID: 26142667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmaniasis.
    Herwaldt BL
    Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Childhood Mediterranean visceral leishmaniasis].
    Cascio A; Colomba C
    Infez Med; 2003 Mar; 11(1):5-10. PubMed ID: 12719664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmaniasis: an update of current pharmacotherapy.
    Sundar S; Chakravarty J
    Expert Opin Pharmacother; 2013 Jan; 14(1):53-63. PubMed ID: 23256501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of visceral leishmaniasis: safety and efficacy.
    Jha RK; Sah AK; Shah DK; Sah P
    JNMA J Nepal Med Assoc; 2013; 52(192):645-51. PubMed ID: 25327244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status and management of canine leishmaniasis in Latin America.
    Marcondes M; Day MJ
    Res Vet Sci; 2019 Apr; 123():261-272. PubMed ID: 30708238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of sand flies (Diptera: Psychodidae) in visceral and cutaneous leishmaniasis areas in the central-western state of Minas Gerais, Brazil.
    Nascimento BW; Saraiva L; Neto RG; Meira PC; Sanguinette Cde C; Tonelli GB; Botelho HA; Belo VS; Silva ES; Gontijo CM; Filho JD
    Acta Trop; 2013 Mar; 125(3):262-8. PubMed ID: 23178219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on pharmacotherapy for leishmaniasis.
    Sundar S; Chakravarty J
    Expert Opin Pharmacother; 2015 Feb; 16(2):237-52. PubMed ID: 25346016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.